STOCK TITAN

1,183 RSUs Listed for Sale by SOPH Insider (NASDAQ: SOPH)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

SOPH: notice of proposed resale of Common Stock tied to Restricted Stock Units. The filing lists 1,183 Restricted Stock Units scheduled on 03/18/2026 for sale. The excerpt also discloses recent Rule 10b5-1 dispositions: examples include 760 shares sold on 02/19/2026 for $3,665.94 and 4,200 shares sold on 01/06/2026 for $20,013.84.

Positive

  • None.

Negative

  • None.

Insights

Form 144 documents proposed resale of RSUs and lists recent 10b5-1 sales.

The filing lists 1,183 Restricted Stock Units slated for sale on 03/18/2026, and shows multiple prior Rule 10b5-1 transactions with specific share counts and dollar amounts. These entries are procedural notices required for resale under securities rules.

Timing and cash‑flow treatment are tied to the reported sale dates; subsequent filings may provide completion details or confirm proceeds disposition.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does SOPH's Form 144 say about the RSUs being sold?

The filing states 1,183 Restricted Stock Units are listed for sale with an effective date of 03/18/2026. This entry is a resale notice describing the securities and proposed sale date as shown in the excerpt.

Who reported the recent share sales shown in the SOPH excerpt?

The excerpt attributes recent Rule 10b5-1 sales to Ross J Muken, listing multiple dispositions including 760 shares on 02/19/2026 and 4,200 shares on 01/06/2026 with dollar amounts shown.

How many shares were sold in recent 10b5-1 transactions in the excerpt?

Examples shown include sales of 760, 760, 4,200, 2,021, and 1,689 shares on dates between 12/26/2025 and 02/19/2026, each with the corresponding dollar amounts displayed in the excerpt.

Does the Form 144 excerpt state who receives the sale proceeds?

The excerpt does not state the recipient of proceeds explicitly. The filing lists the securities, sale dates, and dollar amounts, but the cash‑flow treatment is not described in the provided excerpt.

Is the SOPH filing an indication of open‑market trading or a planned resale program?

The excerpt lists individual Rule 10b5-1 sales and a separate RSU resale entry; it documents proposed and completed dispositions but does not characterize a broader resale program or method beyond the listed transactions.
Sophia Genetics Sa

NASDAQ:SOPH

View SOPH Stock Overview

SOPH Rankings

SOPH Latest News

SOPH Latest SEC Filings

SOPH Stock Data

338.28M
67.30M
Health Information Services
Healthcare
Link
Switzerland
Rolle